MXCT
Maxcyte Inc
$3.95
Earnings Summary
Revenue | $15.67Mn |
Net Profits | $-5.28Mn |
Net Profit Margins | -33.68% |
Highlights
Maxcyte Inc’s revenue jumped 26.1% since last year same period to $15.67Mn in the Q4 2023. On a quarterly growth basis, Maxcyte Inc has generated 95.71% jump in its revenue since last 3-months.
Maxcyte Inc’s net profit fell -83.96% since last year same period to $-5.28Mn in the Q4 2023. On a quarterly growth basis, Maxcyte Inc has generated 53.1% jump in its net profits since last 3-months.
Maxcyte Inc’s net profit margin fell -45.88% since last year same period to -33.68% in the Q4 2023. On a quarterly growth basis, Maxcyte Inc has generated 76.04% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Maxcyte Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.13 |
EPS Estimate Current Year | -0.13 |
Highlights
Maxcyte Inc’s earning per share (EPS) estimates for the current quarter stand at -0.13 - a -85.71% fall from last quarter’s estimates.
Maxcyte Inc’s earning per share (EPS) estimates for the current year stand at -0.13.
Key Ratios
Key ratios of the Maxcyte Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.05 |
Highlights
Maxcyte Inc’s earning per share (EPS) jumped 0% since last year same period to -0.05 in the Q4 2023. This indicates that the Maxcyte Inc has generated 0% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-08-09 | -0.1 | -0.1 | 0% |
2023-11-08 | -0.1 | -0.11 | -10% |
2023-05-10 | -0.11 | -0.11 | 0% |
2024-03-12 | -0.07 | -0.05 | 28.57% |
₹0 US Stocks a/c Opening Fee